Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Approche à adopter pour la prise en charge de la maladie de Ménière.

Wu V, Sykes EA, Beyea MM, Simpson MTW, Beyea JA.

Can Fam Physician. 2019 Jul;65(7):468-472. Review. French.

PMID:
31300427
Free Article
2.

Approach to Ménière disease management.

Wu V, Sykes EA, Beyea MM, Simpson MTW, Beyea JA.

Can Fam Physician. 2019 Jul;65(7):463-467. Review.

3.

Reply to: The role of extracorporeal life support in patients with hypothermic cardiac arrest.

Beyea MM, Tillmann BW, Nagpal AD.

Resuscitation. 2019 Jan;134:159-160. doi: 10.1016/j.resuscitation.2018.10.027. Epub 2018 Nov 2. No abstract available.

PMID:
30395888
4.

Standardizing your approach to dizziness and vertigo.

Wu V, Beyea MM, Simpson MT, Beyea JA.

J Fam Pract. 2018 Aug;67(8):490;492;495;498.

PMID:
30110495
5.

Neurologic outcomes after extracorporeal membrane oxygenation assisted CPR for resuscitation of out-of-hospital cardiac arrest patients: A systematic review.

Beyea MM, Tillmann BW, Iansavichene AE, Randhawa VK, Van Aarsen K, Nagpal AD.

Resuscitation. 2018 Sep;130:146-158. doi: 10.1016/j.resuscitation.2018.07.012. Epub 2018 Jul 11. Review.

PMID:
30017957
6.

β-Blocker dialyzability and mortality in older patients receiving hemodialysis.

Weir MA, Dixon SN, Fleet JL, Roberts MA, Hackam DG, Oliver MJ, Suri RS, Quinn RR, Ozair S, Beyea MM, Kitchlu A, Garg AX.

J Am Soc Nephrol. 2015 Apr;26(4):987-96. doi: 10.1681/ASN.2014040324. Epub 2014 Oct 30.

7.

Risk of acute kidney injury from oral acyclovir: a population-based study.

Lam NN, Weir MA, Yao Z, Blake PG, Beyea MM, Gomes T, Gandhi S, Mamdani M, Wald R, Parikh CR, Hackam DG, Garg AX.

Am J Kidney Dis. 2013 May;61(5):723-9. doi: 10.1053/j.ajkd.2012.12.008. Epub 2013 Jan 10.

PMID:
23312723
8.

Identifying geographical regions serviced by hospitals to assess laboratory-based outcomes.

Gandhi S, Shariff SZ, Beyea MM, Weir MA, Hands T, Kearns G, Garg AX.

BMJ Open. 2013 Jan 3;3(1). pii: e001921. doi: 10.1136/bmjopen-2012-001921.

9.

The oxysterol 24(s),25-epoxycholesterol attenuates human smooth muscle-derived foam cell formation via reduced low-density lipoprotein uptake and enhanced cholesterol efflux.

Beyea MM, Reaume S, Sawyez CG, Edwards JY, O'Neil C, Hegele RA, Pickering JG, Huff MW.

J Am Heart Assoc. 2012 Jun;1(3):e000810. doi: 10.1161/JAHA.112.000810. Epub 2012 Jun 22.

10.

Does orlistat cause acute kidney injury?

Beyea MM, Garg AX, Weir MA.

Ther Adv Drug Saf. 2012 Apr;3(2):53-7. doi: 10.1177/2042098611429985. Review.

11.

Orlistat and acute kidney injury: an analysis of 953 patients.

Weir MA, Beyea MM, Gomes T, Juurlink DN, Mamdani M, Blake PG, Wald R, Garg AX.

Arch Intern Med. 2011 Apr 11;171(7):703-4. doi: 10.1001/archinternmed.2011.103. No abstract available.

PMID:
21482850
12.

Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterol.

Beyea MM, Heslop CL, Sawyez CG, Edwards JY, Markle JG, Hegele RA, Huff MW.

J Biol Chem. 2007 Feb 23;282(8):5207-16. Epub 2006 Dec 23.

Supplemental Content

Loading ...
Support Center